Tamoxifen: An alternative to clomiphene in women with polycystic ovary syndrome
Journal of Human Reproductive Sciences, 2011 Background : Clomiphene citrate is commonly used for ovulation induction in women with anovulatory infertility. However, pregnancy rates with this drug are not as good as ovulation rates.
Lakhbir Kaur Dhaliwal +3 more
doaj +1 more source
The effect of phytoestrogens (Cimicifuga racemosa) in combination with clomiphene in ovulation induction in women with polycystic ovarian syndrome: A clinical trial study [PDF]
Avicenna Journal of Phytomedicine, 2022 Objective: Phytoestrogens can be used as an alternative to clomiphene for ovulation induction in patients with polycystic ovarian (PCO). In this study, we evaluated the impact of phytoestrogens (Cimicifuga racimosa) in combination with clomiphene on the ...
Seyedeh Azam Pourhoseini +3 more
doaj +1 more source
Effects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary Syndrome [PDF]
, 1998 Background Obese women with the polycystic ovary syndrome are relatively unresponsive to the induction of ovulation by clomiphene. We hypothesized that reducing insulin secretion by administering metformin would increase the ovulatory response to ...
Evans, William S., , M.D. +3 more
core +2 more sources
The Effectiveness of Clomiphene Citrate and Letrozole for Ovulation Induction Related to Endometrial Thickness and Number of Dominant Follicle [PDF]
, 2016 The aim of the study is to know the effectiveness of clomiphene citrate and letrozole for ovulationrelated to endometrial thickness and number of dominant follicle. Study design was cross sectional basedon medical records of women who underwent ovulation
Madjid, V. (Veinardi) +3 more
core +2 more sources
ObgyniaObjective: To compare the efficacy of clomiphene citrate and metformin with clomiphene citrate alone in treating primary infertility in women with polycystic ovarian syndrome.
Arifah Mabruroh Prilia +3 more
doaj +1 more source
Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis [PDF]
, 2017 Objective: To compare the effectiveness of alternative first line treatment options for women with WHO group II anovulation wishing to conceive. Design: Systematic review and network meta-analysis.
Bhattacharya, S. +10 more
core +2 more sources
Diyala Journal of Medicine, 2019 Background: Infertility affects about 10-15% of reproductive-age couples. About half the causes of infertility are female related and approximately 40% of the cases are caused by anovulation, mostly in PCO women.
Ali Hassan Mohammed
doaj +2 more sources
Gynecology and Obstetrics Clinical Medicine, 2022 Background: Polycystic ovary syndrome (PCOS) is the leading cause of anovulatory infertility. Clomiphene citrate, insulin-sensitizing drugs, aromatase inhibitors, gonadotropins, or laparoscopic ovarian drilling are various methods used for ovulation ...
Jasmine Kavitha Washington +3 more
doaj +1 more source
Evaluation of the Proarithmic Potential of Clomiphene Citrate in Surface Electrocardiogram
Van Tıp Dergisi, 2020 INTRODUCTION: Clomiphene (diethylethanamine structure) is an anti-estrogen agent that is often used for ovulation induction in the treatment of infertility.
alper karakus +3 more
doaj +1 more source
Clomifeno não reverte o hipogonadismo na maioria dos homens com adenomas pituitários não funcionais tratados de forma convencional [PDF]
, 2011 OBJETIVE: To evaluate the effect of clomiphene in men with hypogonadism and conventionally treated nonfunctioning pituitary adenomas (NFPA). PATIENTS AND METHODS: Open label, single-arm, prospective trial.
Abucham, Julio +1 more
core +3 more sources